Stay updated on OpACIN-neo Optimal Combo Trial

Sign up to get notified when there's something new on the OpACIN-neo Optimal Combo Trial page.
Latest website image capture
Clouds background image

Latest updates to the OpACIN-neo Optimal Combo Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    - Added the Nat Med 2026 PRADO-trial publication: Neoadjuvant ipilimumab plus nivolumab in melanoma: 5-year survival and biomarker analysis (Nat Med, 2026 Mar;32(3):952-963; Epub 2026 Jan 28). - Removed the earlier Nat Med ahead-of-print citation (Nat Med, 2026 Jan 28).
    Difference
    0.0%
    Check dated 2026-04-02T01:37:13.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0. No user-facing content changes were observed on the page.
    Difference
    0.0%
    Check dated 2026-03-18T18:12:06.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Page revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-11T17:22:03.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Administrative updates: a new system revision (v3.4.2) is added, and older notices (including a funding-lapse alert and revision v3.4.1) are removed. These changes do not alter study details.
    Difference
    0.4%
    Check dated 2026-02-11T05:08:20.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    Added an administrative funding notice and a 2026 Nat Med publication citation to Publications, and updated the site revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T03:43:19.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    The page now shows a glossary and includes minor text/capitalization updates (Last Update Submitted that Met QC Criteria vs met QC Criteria, No FEAR Act Data), and the Revision label updated to v3.4.0 from v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T00:44:06.000Z thumbnail image

Stay in the know with updates to OpACIN-neo Optimal Combo Trial

Enter your email address, and we'll notify you when there's something new on the OpACIN-neo Optimal Combo Trial page.